Skip to content
NewsBlazeIN – Lifestyle
Author:
Oculis Holding AG
Oculis to Participate in Upcoming Investor Conferences
April 7, 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
March 31, 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
March 16, 2026
←
Previous Page
1
2